NASDAQ:FATE Investor Alert: Investigation over Potential Wrongdoing at Fate Therapeutics, Inc
August 10, 2018 at 12:15 PM EDT
San Diego, CA -- (SBWIRE) -- 08/10/2018 -- An investigation was announced for investors in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) concerning potential breaches of fiduciary duties by certain officers and directors at Fate Therapeutics, Inc.
